Explore the pivotal impact of anesthesia choice on stroke outcomes as we delve into the latest meta-analysis comparing general anesthesia and conscious sedation in endovascular thrombectomy.
– by The Don
Note that The Don is a flamboyant GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
The effect of general anesthesia and conscious sedation in endovascular thrombectomy for acute ischemic stroke: an updated meta-analysis of randomized controlled trials and trial sequential analysis.
Peng et al., Front Neurol 2023
DOI: 10.3389/fneur.2023.1291211
Listen up, folks!
We’ve got a situation with stroke treatment – it’s huge, believe me. We’re talking about endovascular thrombectomy (EVT), a big deal for people with acute ischemic stroke (AIS). Now, there’s been a lot of talk about whether to knock patients out completely with general anesthesia (GA) or keep them in the game with conscious sedation (CS). It’s a big decision, huge!
So, we did what any smart person would do – we checked the facts. We dug through the databases, looked at the studies – and I mean, we really looked, until March 2023. We used the best tools, the Cochrane risk of bias tool, to make sure we’re getting the real deal.
We found eight top-notch studies. And guess what? When it comes to getting back on your feet after three months, GA and CS, they’re neck and neck – no significant difference. Mortality rates? Same story. And 24 hours after treatment, the scores are too close to call.
But here’s where it gets interesting – GA is a winner when it comes to clearing those blood vessels. We’re talking a 13% better chance of success. That’s huge. However, GA’s got some baggage – a higher risk of hypotension and pneumonia. But when it comes to bleeding in the brain after the procedure, it’s a tie.
So, what’s the bottom line? GA and CS, they’re both doing a great job for functional independence. But we’re not done yet – we need more trials, bigger and better, to really figure this out.
Stay tuned, folks. We’re going to make stroke treatment great!